期刊
EXPERIMENTAL AND THERAPEUTIC MEDICINE
卷 1, 期 2, 页码 257-264出版社
SPANDIDOS PUBL LTD
DOI: 10.3892/etm_00000040
关键词
cyclooxygenase-2; peroxisome proliferator-activated receptor gamma; prostaglandins; nonsteroidal anti-inflammatory drugs
资金
- Czech Science Foundation [301/09/1115, 204/08/H054]
- Ministry of Education, Youth and Sports of the Czech Republic [MSM0021622415]
- Masaryk University [MUNI/0099/2009]
Increased production of the pro-inflammatory enzyme cyclooxygenase-2 (Cox-2) and altered expression and activity of peroxisome proliferator-activated receptor gamma (PPAR gamma) have been observed in many malignancies. Both the PPAR gamma ligands and the Cox-2 inhibitors possess anti-inflammatory and anti-neoplastic effects in vitro and have been assessed for their therapeutic potential in several pre-clinical and clinical studies., Recently, multiple interactions between PPAR gamma and Cox-2 signaling pathways have been revealed. Understanding of the cross-talk between PPAR gamma and Cox-2 might provide important novel strategies for the effective treatment and/or prevention of cancer. This article summarizes recent achievements involving the functional interactions between the PPAR gamma and Cox-2 signaling pathways and discusses the implications of such interplay for clinical use.
作者
我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。
推荐
暂无数据